Evidence map›Paper›PMID 40305024›Full record

ArticleJAMA network open2025

Nicotine Pouch and E-Cigarette Use and Co-Use Among US Youths in 2023 and 2024.

Dae-Hee Han, Alyssa F Harlow, Richard A Miech, Dayoung Bae, Junhan Cho, Hongying D Dai, Steven Y Sussman, Louisiana M Sanchez, Leah Meza, Adam M Leventhal

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The feasibility and acceptability of Live Free From E-Cigarettes (LIFFE): A web-based vaping intervention and smoking prevention program for young adults.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nicotine pouches: A wolf in sheep's clothing.Tobacco prevention & cessation · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dae-Hee HanDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Alyssa F HarlowDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Richard A MiechInstitute for Social Research, University of Michigan, Ann Arbor.
Dayoung BaeDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Junhan ChoDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Hongying D DaiDepartment of Biostatistics, University of Nebraska Medical Center, Omaha.
Steven Y SussmanDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Louisiana M SanchezDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Leah MezaDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Adam M LeventhalDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.

Funding

Monitoring the Future: Drug Use & Lifestyles of American Youth (Supp1: Nicotine Pouch and E-cigarette Use Among US Adolescents: National Estimates of Brand Use and Flavor Preferences)R01DA001411 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Richard A Miech · 1985 to 2026
$144.9M
Tobacco Use Treatment Research for Vulnerable PopulationsK24DA048160 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Adam Matthew Leventhal · 2019 to 2026
$1.4M
The Tobacco and Cannabis Retail Environment, Neighborhood Disadvantage, and Adolescent VapingK01DA058084 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Alyssa Fitzpatrick Harlow · 2023 to 2026
$752k
Effect of Product Characteristics on the Abuse Liability of Nicotine PouchesK99DA058241 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAN, DAE HEE · 2024 to 2025
$312k
NIDA NIH HHS K01 DA058084NIDA NIH HHS K24 DA048160NIDA NIH HHS K99 DA058241NIDA NIH HHS R01 DA001411
6 · The paper itself

Abstract

Importance: The market sector of flavored commercial nicotine products without tobacco leaves recently expanded to nicotine pouches. Comprehensive epidemiologic analyses of patterns and trends in youth use of commercial nontobacco nicotine products are lacking. Objective: To estimate US youth nicotine pouch and e-cigarette use prevalence and associated sociodemographic variables in 2023 and 2024. Design, Setting, and Participants: This cross-sectional study used data from annual surveys conducted in school with a nationally representative sample of 10th and 12th graders in 2023 and 2024 as part of the Monitoring the Future Study. Exposures: Self-reported sex, race, ethnicity, and college plans; survey year; grade; and population density. Main Outcomes and Measures: The primary outcomes were lifetime, past-12-month, and past-30-day self-reported nicotine pouch (yes or no) and e-cigarette (yes or no) use and co-use patterns (exclusive pouch without e-cigarettes, exclusive e-cigarette without pouches, or dual use). Results: Of the 10 146 study participants (4886 [48.2%] male and 4818 [47.3%] female; 5674 [51.6%] in 10th grade and 4472 [48.4%] in 12th grade), nicotine pouch use increased from 2023 vs 2024 for lifetime use (3.0% [95% CI, 2.3%-4.0%] vs 5.4% [95% CI, 4.2%-6.8%]; risk difference [RD], 2.3% [95% CI, 1.0%-3.6%]; risk ratio [RR], 1.76 [95% CI, 1.30-2.40]), use in the past 12 months (2.4% [95% CI, 1.7%-3.2%] vs 4.6% [95% CI, 3.5%-5.9%]; RD, 2.2% [95% CI, 1.0%-3.4%]; RR, 1.95 [95% CI, 1.39-2.74]), and use in the past 30 days (1.3% [95% CI, 0.8%-1.8%] vs 2.6% [95% CI, 1.9%-3.4%]; RD, 1.3% [95% CI, 0.5%-2.1%]; RR, 2.05 [95% CI, 1.33-3.16]). E-cigarette use did not significantly change from 2023 to 2024 for lifetime use (28.5% [95% CI, 26.3%-30.7%] vs 26.7% [95% CI, 24.3%-29.3%]) and past-30-day use (13.4% [95% CI, 11.8%-15.2%] vs 11.8% [95% CI, 10.2%-13.7%]) but decreased for past-12-month use (20.0% [95% CI, 18.1%-22.0%] vs 17.6% [95% CI, 15.7%-19.7%]). From 2023 to 2024, exclusive nicotine pouch and pouch plus e-cigarette dual use generally increased, whereas exclusive e-cigarette use decreased, collectively constituting no significant change in the prevalence of any nontobacco nicotine use (using 1 or both products) across years. Demographic comparisons collapsed across 2023 to 2024 found that (1) male individuals reported higher nicotine pouch use prevalence than female individuals, whereas female individuals reported higher e-cigarette use prevalence than male individuals; (2) rural vs urban and non-Hispanic White vs Hispanic youths were more likely to use each product, with larger differences for pouches than e-cigarettes; and (3) nicotine pouch and e-cigarette use prevalence was higher among 12th vs 10th graders and those without vs with 4-year college plans. Conclusions and Relevance: In this cross-sectional study, commercial nontobacco nicotine use in US 10th and 12th graders shifted from 2023 to 2024, marked by a doubling in nicotine pouch past-30-day use, an increase in pouch plus e-cigarette dual use, and a decrease in exclusive e-cigarette use. Prioritizing surveillance, regulation, and prevention addressing pediatric nicotine pouch use warrants consideration.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsVapingAdolescentCross-Sectional StudiesFemaleHumansMalePrevalenceSelf ReportUnited States

Identifiers

PMID40305024
PMCPMC12044512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.